Quantum Cyber N.V. (QUCY): Gross Profit
$389.8K
Year ended 2025-12-31
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $389.8K | -32.2% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $574.9K | n/a | 2026-03-31, From 2024-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $389.8K | -32.2% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $344.0K | -98.9% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $185.3K | n/a |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $478.0K | +288.6% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $460.1K | n/m |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $331.5K | n/m |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $703.2K | +53.1% |
| Hyperion Defi, Inc. (HYPD) | 2025-12-31 | $510.2K | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $632.9K | -40.0% |
Compare QUCY, SLN, ELAB, BTAIQ side by side · Screen every company in Pharmaceutical Preparations ↗